Angelika Joos is a licensed pharmacist. Since 2001 she is responsible for regulatory policy issues at Merck Sharp & Dohme's Regulatory Affairs department in Brussels. Before focusing on policy she was working at the European and German Regulatory Affairs departments of MSD as well as for Nycomed Arzneimittel GmbH. Over the past 15 years, Angelika has gained strategic as well as operational experience with all regulatory procedures and various products in different therapeutic areas. In her current position as Head Regulatory Policy EU & Most of World she is responsible for monitoring and implementing regulatory policies & procedures and advising the company on regulatory strategies. One of her current priorities includes the implementation of the Paediatric Regulation into the EU regulatory framework. Since 2004 she is a member of the EFPIA Regulatory Liaison Committee and specifically involved in activities related to paediatric policies. She is also a company delegate to the IFPMA Pediatric Task Force established in 2008. In addition she is co-chairing the global Merck Pediatric Development Committee since 2011.